Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 15:883:173373.
doi: 10.1016/j.ejphar.2020.173373. Epub 2020 Jul 15.

Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Antonio Vitiello  1 , Francesco Ferrara  2
Affiliations

Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?

Antonio Vitiello et al. Eur J Pharmacol. .

Abstract

The first cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19) infections were recorded in China in November 2019. Since its appearance in China at the end of last year, the virus has spread to all continents causing a "global pandemic". To date, some aspects remain to be investigate about the pathophysiology of this viral infection. One of the aspects to be still clarified is the correlation between the renin-angiotensin system (RAS) and SARS-CoV-2 infection. RAS is a physiological system playing a key role in different human body functions regulation. SARS-CoV-2 uses the angiotensin-converting enzyme 2 (ACE-2), a component of RAS, as a potential factor of cell penetration and infectivity; in addition, in the different infection stages, a functional variation of the RAS has been noted. In this article, we discuss the correlation between the role of RAS and system-modifying agents, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers (ARBs) and direct renin inhibitors (DRIs), with SARS-CoV-2 infection.

Keywords: ACE-2; Coronavirus; Infection; Pharmacology; RAS; Renin; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

None of the Authors have conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Atlas S.A. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J. Manag. Care Pharm. 2007;13:9–20. doi: 10.18553/jmcp.2007.13.s8-b.9. - DOI - PMC - PubMed
    1. Bavishi C., Bangalore S., Messerli F.H. Renin angiotensin aldosterone system inhibitors in hypertension: is there evidence for benefit independent of blood pressure reduction? Prog. Cardiovasc. Dis. 2016;59:253–261. doi: 10.1016/j.pcad.2016.10.002. - DOI - PubMed
    1. Bavishi C., Maddox T.M., Messerli F.H. Coronavirus disease 2019 (COVID-19) infection and renin angiotensin system blockers. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1282. - DOI - PubMed
    1. Chen Q., Yang Y., Huang Y., Pan C., Liu L., Qiu H. Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury. J. Surg. Res. 2013;185:740–747. doi: 10.1016/j.jss.2013.06.052. - DOI - PubMed
    1. European Society of Hypertension . 2020. Statement of the European Society of Hypertension (ESH) Hypertension, the Renin–Angiotensin System, and the Risk of Lower Respiratory Tract Infections and Lung Injury: Implications for COVID-19. - DOI - PMC - PubMed

MeSH terms

Substances